CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma.

Authors :: Messori A
Damuzzo V
Leonardi L
Agnoletto L
Chiumente M
Mengato D
Source :: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Jul; Vol. 20 (7), pp. 490-491. Date of Electronic Publication: 2020 Feb 19.
Publication Year :: 2020

Subjects :: Humans
Lymphoma, Large B-Cell, Diffuse mortality
Lymphoma, Large B-Cell, Diffuse therapy
Receptors, Chimeric Antigen therapeutic use

Full Text Access

Tools